IPO: Aristo Bio-Tech And Lifescience Limited's Initial Public Offering (IPO) Is Open Today

IPO: Aristo Bio-Tech And Lifescience Limited's Initial Public Offering (IPO) Is Open Today

Today, January 16, Aristo Bio-Tech And Lifescience Limited begins its initial public offering. With the issue, the company hopes to raise Rs 13.05 crore. The company is issuing 18,12,800 shares at Rs 72 per share. Investors may submit bids for a minimum of 1,600 shares or subsequent multiples. High net worth individuals (HNIs) will receive 50% of the Aristo Bio-Tech And Lifescience Limited public issue, while retail investors will receive 50%. The IPO is scheduled to end on January 19, 2023. On January 27, it is anticipated to go public on the NSE Emerge platform.

Aristo Bio-Tech IPO Date & Price Band Details

IPO Open: January 16, 2023
IPO Close: January 19, 2023
IPO Size: Approx ₹13.05 Crores, 1,812,800 Equity Shares
Face Value: ₹10 Per Equity Share
IPO Price Band: ₹72 Per Equity Share
IPO Listing on: NSE SME
Retail Quota: 50% of the net offer
NII Quota: 50% of the net offer

Beeline Capital Advisors Private Limited, a well-known Gujarati merchant banking company, is the issue’s lead manager. Link Intime Financial Services Private Limited is the registrar of the offer. The company will use Rs 935.22 lakh of the total amount raised in the issue to meet its working capital requirements. As opposed to this, Rs. 250 lakh will be used for general corporate purposes, and Rs. 120 lacks will be allocated to pay issue fees.

Also Read,

Homesfy Realty IPO Has Officially Started; Here Is Everything You Need To Know About The SME Proptech Company

Aristo Bio-Tech IPO Dates

IPO Open Date: January 16, 2023
IPO Close Date: January 19, 2023
Basis of Allotment: January 24, 2023
Refunds: January 25, 2023
Credit to Demat Account: January 26, 2023
IPO Listing Date: January 27, 2023

According to Avinash Gorakshakar, Head of Research at Profitmart Securities, Aristo Bio-Tech is a significant player in the agrochemical industry with a broad range of branded and technical formulations in its product offering. He continued by saying the business had performed admirably in FY22. Gorakshakar said he hoped the company would report sound topline and profit growth in FY23. The domestic agrochemicals industry presents a strong business opportunity for the upcoming two to three years, according to Avinash. He said that if one considers the company’s long-term prospects, one can subscribe for two years.

Aristo Bio-Tech Company Financial Report

Crop protection company Aristo Bio-Tech provides manufacturing, formulation, supply, and packaging services for different pesticides. It provides its services for various other agrochemicals, including plant growth regulators, fungicides, insecticides, and herbicides in India and export.

The company also provides reputable Indian and international crop protection companies with contract manufacturing, job work, and toll manufacturing services and goods.

₹ in Crores
Year Revenue Expense PAT
2020 ₹201 ₹200 ₹1.01
2021 ₹167 ₹166 ₹1.08
2022 ₹166 ₹164 ₹1.46
2023 6M ₹129 ₹125 ₹2.59

Status of the Aristo Bio-Tech IPO allocations

Visit the Linkintime website to check the status of Aristo Bio-IPO Tech’s allotments. Click Here

Aristo Bio-Tech IPO Frequently Asked Questions

What exactly is the Aristo Bio-Tech initial public offering?

The NSE SME IPO Aristo Bio-Tech. They plan to raise 13.05 crores through an IPO. The issue is priced at 72 cents per share of the equity. The IPO will be listed on the NSE.

When will the Aristo Bio-Tech initial public offering begin?
The IPO will be open to NII and retail investors on January 16, 2023.

What is the Aristo Bio-Tech initial public offering Investors Share?
The investor portion of NII is 50%, and the retail portion is 50%.

What is the Aristo Bio-Tech initial public offering process?

Applying for Aristo Bio-Tech IPO through ASBA online using your bank account is possible. You can also use your stock brokers to submit an online ASBA application via UPI. You can apply by completing the offline form and submitting it through your stock brokers.

Also Read,

The next big thing : Will TradeTech ever rule the world?


Leave a Reply

Your email address will not be published. Required fields are marked *